Celebrex, an anti-inflammatory drug that provides pain relief for arthritis sufferers, is available as generic Celebrex in most countries outside of the United States. Generic Celebrex will only be available in America after 2013.

In the United States, Celebrex has been exclusively patented by the Pfizer drug company until 2013. Since Pfizer owns the intellectual property of the prescription drug, there is no generic Celebrex allowed in America. However, in other countries, including India and Canada, generic Celebrex is legally sold.

When Pfizer’s patent for Celebrex expires in 2013, several companies can begin to manufacture a generic Celebrex. Until their time is up, patients who cannot afford brand name Celebrex drugs should consider the option of purchasing generic Celebrex from a Canadian online pharmacy.

For more information on generic Celebrex and other anti-inflammatory generic drugs, visit http://www.orderonlinedrugs.com

Flomax, also known as Tamsulosin, is a prescription drug used to treat an enlarged prostate. Flomax helps improve urination for men suffering from benign prostatic hyperplasia. Flomax has a minimum amount of side-effects and generic Flomax is an affordable option for patients.

How Flomax works:

Flomax blocks the alpha-1 receptors that are commonly found throughout the body and in the prostate. When the receptors are blocked the muscles relax in the prostate and bladder neck. Flomax stands out from other prostate medication because it does not shrink the prostate. Flomax is prescribed to provide relief from enlarged prostate symptoms, but it is not a complete cure for the condition.

Flomax in recent news:

In April, two of the world’s largest generic drug makers began selling their own versions of generic Flomax. They are the second and third companies to start selling the authorized generic drug. Flomax is now widely available for patients wishing to treat painful urination from an enlarged prostate.

For more information on Flomax and how to buy Flomax online, visit http://www.orderonlinedrugs.com

A major study has concluded that cure and treatment of a heart attack with Plavix can save lives and reduce the chance of a second heart attack or stroke. The recent clinical trial studied the value of Plavix (clopidogrel) in regards to the cure and treatment of a heart attack patient in cardiac care.

Researchers reported a 50 percent reduction in deaths and other major problems experienced by heart attack patients who received Plavix before, rather than during, artery-opening angioplasty.

Dr. Rory Collins, a professor of medicine and epidemiology at the University of Oxford in England said that “our study shows is that [Plavix] translates into an increase in survival and a reduction of second heart attacks.” These results could change medical practice.

This study of the cure and treatment of a heart attack took place in China and included more than 45,800 patients treated at the start of a heart attack at 1,250 hospitals. Half of these patients were given aspirin, while the rest were treated with Paxil.

The patients who received Paxil for the cure and treatment of a heart attack experienced a 7% lower death rate. In addition, the incidence of a second heart attack during the treatment period was 14% lower and the overall incidence of repeat heart attacks, stoke and death was 9% lower.

For more information on the cure and treatment of a heart attack with Plavix, visit http://www.orderonlinedrugs.com

“The Human Immunodeficiency Virus (HIV) has infected around 0.6% of the world’s population.”

HIV infects the human immune system, the complex system that fights off infection and keeps a person healthy. HIV causes a weakened immune system, which can become very serious and life-threatening. When infected with HIV, a person is more vulnerable to a wide range of infections, diseases and cancers.

HIV causes symptoms and prevention begins with the transmission of the disease through infected body fluids such as vaginal secretions, semen, pre-semen, breast milk, and blood. Infection can happen through anal, vaginal or oral sex, as well as through shared needles, and infected breast milk.

HIV causes symptoms that can be easily confused with other illnesses, such as weight loss, fatigue, night sweats, and loss of appetite, persistent diarrhea and recurring yeast infections. HIV infection may not be suspected until the symptoms fail to go away or the person is at a high risk of HIV infection because of past sexual behavior or injection drug use. Remember that HIV symptoms can only be confirmed by testing for the disease.

Educating younger people about HIV causes symptoms and prevention is one of the best ways to stop the disease from spreading. You can protect yourself against HIV by using condoms every single time you have sex. Getting tested or treated for STIs can also help greatly reduce the risk of contracting HIV. In other parts of the world, HIV symptoms are much more common than in developed countries. Educate yourself, be aware, and always wear protection.

For more information on HIV causes symptoms and prevention, visit http://www.orderonlinedrugs.com

Chinese folk medicine has been using Daidzin, the material found in kudzu, to treat alcoholism for some time. It suppresses human aldehyde dehydrogenase 2 (ALDH-2), which metabolizes alcohol into acetaldehyde. This then produces a buildup of acetaldehyde, creating disagreeable effects, such as, flushing and feeling ill.

During research on rodents, scientists found that a simulated ALDH-2 inhibitor CVT-10216, lessened drinking and restrained relapse. While the rodents were drinking alcohol CVT-10216 intensified their acetaldehyde followed by lessening dopamine in their brain regions that manages relapse during abstinence.

Ivan Diamond, one of the study’s authors proclaimed that they “had several key findings … [one being that] CVT-10216 is a highly selective reversible inhibitor of ALDH2 without apparent toxicity … Two, treatments with our ALDH-2 inhibitor increases acetaldehyde in the test tube and in living animals. And three, we found that ALDH-2 inhibitor suppressed drinking in a variety of rodent drinking models.”

Interestingly, the study also found that “CVT-10216 prevents the usual increase in [binge] drinking that occurs after five days of abstinence, and also prevents relapse to drink, even when alcohol is not present.” Diamond goes on to state that they believe “This means there is something else besides acetaldehyde helps to suppress craving for, and prevent relapse to, drinking alcohol. And we believe that ‘something else’ is dopamine.”

The scientific study, which will appear in the Proceedings of the National Academy of Science, explain that interactions among proteins are of a biological nature, which includes tumor growth and infection.  By disrupting these interactions, the HIV virus is unable to contaminate cells.

Chemistry professor Samuel Gellman of the University of Wisconsin-Madison explains “There’s a lot of information transfer that occurs when proteins come together, and one would often like to block that information flow.”

Synthetic peptide – like molecules have prevailed past attempts at protein interference, because of their altered structures that enzymes are unable to identify.  The lab’s synthetic molecules had been changed, in order to enhance their ability capability to resist enzyme degradation, yet at the same time maintaining their three-dimensional form, mandatory for HIV gp14 protein recognition.

In simple terms Gellman stated that the effort to “find an alternative language, an alternative way to express the information that the proteins express [means we can] interfere with a conversation that one protein is having with another,” he adds that their research will potentially lead to generate alternative treatments for other diseases-causing protein interactions, such as influenza and Ebola virus.

The Food and Drug Administration allowed for the distribution of Zyprexa Relprevv in the form of an injection. It will be used for the treatment of schizophrenia in adults and can last up to four weeks.

Eli Lilly & Co already distributes a top-selling pill-form of Zyprexa that is taken daily along with an injection of the drug that acts rapidly in the body to treat agitation.

This new version of the anti-psychotic will be given to patients either bi-weekly or monthly, depending on their level of dosage, announced spokeswoman Janell Smith.

Smith also added that this longer-lasting medication will make it simpler for patients to stay on medication while allowing doctors to monitor how each patient is doing.

Zyprexa has been Eli Lilly & Co’s most popular drug for several years and has made them around $4.7 billion in sales.

University experts also believe that the price of drugs comes from the shielding of insured consumers from the true prices of drugs, patent laws, and the intricate structure of the pharmaceutical industry.

For example, if a consumer were to buy Advair at a Walgreen’s, the price would be around $151.59 for a month’s supply. From an online Canadian pharmacy, Advair prices range from $114-134.00 for a two month supply.

American prices became really high beginning in the 1970s and 1980s, because companies were pricing their medication based on the country’s median income. Drug prices in Canada are running at around 50-60% of the U.S. figure, while Europe is about 40-50%.

The U.S. is the only developed country in the world that does not regulate drug prices. In 2002, the ten major American Drug companies had a 17% which can be compared to a 3.1% for all other Fortune 500 industries. The drugs that are the most popular on the market are usually developed at government or university labs.

With a new senate bill being debated, concerning the legalization of the personal drug importation by Americans, the prices of American prescription drugs will be forced to change in order to compete.

In order to promote usage of the drug and a better understanding of risks, researchers at the University Of Michigan Comprehensive Cancer Center made a decision aid, made with the health history of 632 women participating in the study.

“That means, when women read this decision aid, they learned about how the drug was likely to affect them given their age, race, breast cancer history and medical history,” said study author Angela Fagerlin, an associate professor of internal medicine at the University of Michigan Medical School and a research investigator at the VA Ann Arbor Healthcare System in a university news release.

Researchers asked questions to the women about the risks and benefits of tamoxifen. Out of six questions, 63% correctly answered at least five and 41% answered all six questions with the right answer.

While these women seemed to have a firm grasp of understanding regarding the drug, only 29% said they would pursue any research on the drug, another 29% said that they would talk to a doctor about it and only 6% said they would actually take tamoxifen.

The major aversion to the medication came from the side effects, which include hot flashes, sexual problems and, in very rare cases, blood clots, cataracts or endometrial cancer.

Experts often lament about the lack of women taking the canadian prescription drugs, many think that word has not spread about the ability of breast cancer prevention. However, this study has revealed that women are aware about tamoxifen, they are just too worried about the pill’s side effects.

The study can be found in an upcoming Breast Cancer Research and Treatment.

GlaxoSmithKline recently advised the public that the US FDA’s Vaccines and Related Biological Products Advisory Committee voted that Ceravix, the company’s cervical cancer vaccine, presented data that substantiates the efficacy and safety of the treatment.

With regards to the prevention of cervical pre-cancers and cervical cancer relevant to human papillomavirus (HPV) types 16 and 18, Ceravix proved to be both extremely impactful and satisfactory endured in girls and young women.  In addition, the committee conversed on data which presented Ceravix’s efficacy while in contact with other cancer-causing viruses.

GlaxoSmithKline’s Vice President and Director of North American Vaccine Development, Barbara Howe, MD exclaims that their recent favorable FDA recommendations marks and “important step in cancer prevention for the millions of girls and young women at risk for cervical cancer … if approved, Ceravix will help provide protection against cervical cancer, a devastating disease that is responsible for thousands of deaths in US women each year.”

The FDA will review the committee’s commendatory advice during its concluding evaluation of the Biologics License Application for the candidate vaccine.  If accepted, the FDA will finalize prescribing information.

General side effects displayed during clinical trials of the Ceravix vaccine were pain, swelling and redness, fatigue, headache, muscle ache and joint pain, gastrointestinal  symptoms and fever.  Major side effects were mainly similar between the groups who received Ceravix and the control groups.

March of 2009, marks the date when GSK presented their Phase III pivotal study concluding data, a trial study that was the biggest efficacy trial of a cervical cancer vaccine.  The data included information harvested from clinical trials hosted in more than 30 countries which utilized 30,000 Ceravix participants, revealing an ethnically and racially varied female population.  The study also covered a rigorous safety assessment  applicable to girls and young women between the ages of 10-25.

]]> http://www.orderonlinedrugs.com/daily-health-and-medical-news/2009/09/10/ceravix-receives-commendatory-advice-from-fda-advisory-committee/feed/ 1